This HTML5 document contains 38 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n13http://linked.opendata.cz/resource/drugbank/drug/DB08399/identifier/chebi/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB08399/identifier/pdb/
n9http://linked.opendata.cz/resource/drugbank/drug/DB08399/identifier/pubchem-compound/
n6http://bio2rdf.org/drugbank:
n10http://linked.opendata.cz/resource/drugbank/drug/DB08399/identifier/pubchem-substance/
admshttp://www.w3.org/ns/adms#
n11http://linked.opendata.cz/resource/drugbank/drug/DB08399/identifier/drugbank/
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n14http://linked.opendata.cz/resource/drugbank/drug/DB08399/identifier/chemspider/

Statements

Subject Item
n2:DB08399
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB08399 n7:DB08399
dcterms:title
PICEATANNOL
adms:identifier
n9:667639 n10:99444870 n11:DB08399 n12:PIT n13:28814 n14:581006
n3:synthesisReference
Alain Schouteeten, Sebastien Jus, Jean-Claude Vallejos, "Novel Process For The Synthesis Of (E)-Stilbene Derivatives Which Makes It Possible To Obtain Resveratrol And Piceatannol." U.S. Patent US20100004483, issued January 07, 2010.
n3:IUPAC-Name
n4:271B5465-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B546B-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B546A-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5467-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5468-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5469-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5463-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5464-363D-11E5-9242-09173F13E4C5 n4:271B5461-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5462-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5471-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5472-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B546C-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B546D-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B546F-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B546E-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5470-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5477-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5479-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B547A-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5476-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5475-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5478-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5466-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5473-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5474-363D-11E5-9242-09173F13E4C5